{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:32:44Z","timestamp":1770435164900,"version":"3.49.0"},"reference-count":75,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2019,11,2]]},"DOI":"10.1080\/14760584.2019.1690457","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T09:16:02Z","timestamp":1573118162000},"page":"1115-1126","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age"],"prefix":"10.1080","volume":"18","author":[{"given":"Pablo","family":"Obando-Pacheco","sequence":"first","affiliation":[{"name":"Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Hospital Cl\u00ednico Universitario and Universidad de Santiago de Compostela (USC)","place":["Galicia, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3678-9264","authenticated-orcid":false,"given":"Irene","family":"Rivero-Calle","sequence":"additional","affiliation":[{"name":"Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Hospital Cl\u00ednico Universitario and Universidad de Santiago de Compostela (USC)","place":["Galicia, Spain"]},{"name":"Department of Pediatrics, Translational Pediatrics and Infectious Diseases, Hospital Cl\u00ednico Universitario de Santiago de Compostela","place":["Galicia, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9716-4746","authenticated-orcid":false,"given":"Peter Francis","family":"Raguindin","sequence":"additional","affiliation":[{"name":"Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Hospital Cl\u00ednico Universitario and Universidad de Santiago de Compostela (USC)","place":["Galicia, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-581X","authenticated-orcid":false,"given":"Federico","family":"Martin\u00f3n-Torres","sequence":"additional","affiliation":[{"name":"Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Hospital Cl\u00ednico Universitario and Universidad de Santiago de Compostela (USC)","place":["Galicia, Spain"]},{"name":"Department of Pediatrics, Translational Pediatrics and Infectious Diseases, Hospital Cl\u00ednico Universitario de Santiago de Compostela","place":["Galicia, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"e_1_3_5_3_1","unstructured":"World Health Organization. Immunization vaccines and biologicals: data statistics and graphics. 6. Immunization schedule Geneva Switzerland. 2019. [cited 2019 May 9]. Available from: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/en\/"},{"key":"e_1_3_5_4_1","unstructured":"Advisory Commitee on Immunization Practice (ACIP). Recommended child and adolescent immunization schedule for ages 18 years or younger United States 2019. Maryland: US Centers for Disease Control and Prevention; 2019. [cited 2019 May 7]. Available from: https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child-adolescent.html#vaccines-schedule"},{"key":"e_1_3_5_5_1","unstructured":"Joint Committee on Vaccines and Immunisations. The routine immunisation schedule: autumn 2018 London: National Health Service and Public Health England; 2018. [cited 2019 Apr 4]. Available from: https:\/\/www.gov.uk\/government\/publications\/the-complete-routine-immunisation-schedule"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix054"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000222413.47344.23"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1362515"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31805d7f17"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-59952-6_20"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1044180"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200111001-00002"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.1.6.2377"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.11.115"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.053"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000437806.76221.20"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182717edf"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1084451"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26269"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.030"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.08.135"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1098-3015(10)74244-3"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S87229"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit048"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/589862"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01339-14"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1324149111"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.03.046"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.034"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-0090-5.00030-6"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90246-I"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.930667"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00641-13"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2009.02521.x"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00355-12"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00227-8"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1445530"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz199"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-0090-5.00015-X"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.5.2093-2098.1998"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04377-9"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80684-X"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00053-11"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26109"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.026"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001405"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-4102"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.043"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.05.054"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001406"},{"key":"e_1_3_5_51_1","volume-title":"NCT01553279: Immunogenicity and safety of V419 (PR51) in combination with MCC in infants and toddlers (V419-011)","author":"ClinicalTrials.gov","year":"2019","unstructured":"ClinicalTrials.gov. NCT01553279: Immunogenicity and safety of V419 (PR51) in combination with MCC in infants and toddlers (V419-011). Maryland, BD: US National Library of Medicine; 2019."},{"key":"e_1_3_5_52_1","volume-title":"NCT02759354: long-term persistence of hepatitis B and pertussis antibody responses in healthy 4- to 5 year old children previously vaccinated with VAXELIS or INFANRIX hexa","author":"ClinicalTrials.gov","year":"2017","unstructured":"ClinicalTrials.gov. NCT02759354: long-term persistence of hepatitis B and pertussis antibody responses in healthy 4- to 5 year old children previously vaccinated with VAXELIS or INFANRIX hexa. Maryland, BD: US National Library of Medicine; 2017."},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.4161\/21645515.2014.970494"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-016-0208-y"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.11.053"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002257"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1977"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.027"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-0665"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.07.027"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12444"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.10.100"},{"key":"e_1_3_5_63_1","unstructured":"Oliver JL Snape MD Heath PT et al. Hexavalent vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during primary series. In: 33rd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID): 2015 May 12\u201316; Leipzig Germany."},{"key":"e_1_3_5_64_1","unstructured":"American Academy of Pediatrics. Immunization Schedules | Red Book Online | AAP Point-of-Care-Solutions. 2019 Mar 12. Available from: https:\/\/redbook.solutions.aap.org\/selfserve\/ssPage.aspx?SelfServeContentId=Immunization_Schedules"},{"key":"e_1_3_5_65_1","unstructured":"Wilck MB Xu Z J Stek JE et al. Safety and immunogenicity of Vaxelis in preterm infants. In:\u00a037th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) 2019 May 6\u201311; Ljubljana Slovenia."},{"key":"e_1_3_5_66_1","volume-title":"Vaxelis summary of products characteristics","author":"European Medicines Agency","year":"2016","unstructured":"European Medicines Agency. Vaxelis summary of products characteristics. London; 2016. Contract No 2019 Mar 12."},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.10.059"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1177\/000992280304200201"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.094"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.09.049"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.063"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.28642"},{"issue":"2","key":"e_1_3_5_73_1","first-page":"E107","article-title":"Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts","volume":"59","author":"Orsi A","year":"2018","unstructured":"Orsi A, Azzari C, Bozzola E, et al. Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts. J Prev Med Hyg. 2018;59(2):E107\u2013E19.","journal-title":"J Prev Med Hyg"},{"key":"e_1_3_5_74_1","unstructured":"European Medicines Agency. 1. 2012. Contract No. 2019 Mar 12."},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1268920"},{"key":"e_1_3_5_76_1","unstructured":"US Food and Drugs Administration. Vaxelis Approval letter; 2018. [cited 2019 May 9].\u00a0Available from: https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/UCM629110.pdf"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.11.045"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2019.1690457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:52:41Z","timestamp":1770385961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2019.1690457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,2]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11,2]]}},"alternative-id":["10.1080\/14760584.2019.1690457"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2019.1690457","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-06-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}